Clinical Experience with Dextro-alprenolol
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Experience with dextro-alprenolol in nine patients has shown that it is relatively ineffective in treating arrhythmias associated with acute myocardial infarction. Marginal effectiveness in the control of ventricular ectopic beats after myocardial infarction is outweighed by an appreciable hypotensive effect with risk of infarction. The drug was ineffective in the management of supraventricular arrhythmias.
Citing Articles
Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
EKELUND L, Melcher A, Oro L Eur J Clin Pharmacol. 1971; 3(4):198-203.
PMID: 5151303 DOI: 10.1007/BF00565006.
References
1.
Epstein S, Braunwald E
. Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med. 1966; 275(20):1106-12 contd.
DOI: 10.1056/NEJM196611172752006.
View
2.
Lord C, Katz R, Eakins K
. Antiarrhythmic properties of stereoisomers of a beta-adrenergic blocking agent (H56-28). Anesthesiology. 1968; 29(2):288-94.
DOI: 10.1097/00000542-196803000-00011.
View
3.
LINKO E, RUOSTEENOJA R, SIITONEN L
. A clinical study on the mechanism of the antiarrhythmic action of a new antagonist to beta-adrenergic receptor. Am Heart J. 1968; 75(1):139-40.
DOI: 10.1016/0002-8703(68)90125-7.
View
4.
SLOMAN G, Stannard M
. Beta-adrenergic blockade and cardiac arrhythmias. Br Med J. 1967; 4(5578):508-12.
PMC: 1749176.
DOI: 10.1136/bmj.4.5578.508.
View